Trial Profile
Phase I trial of polysialylated erythropoietin (ErepoXen) in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2014
Price :
$35
*
At a glance
- Drugs Erythropoietin (Primary)
- Indications Anaemia
- Focus Adverse reactions
- 27 Nov 2014 New trial record